[Myocardial laser revascularization in therapy-refractory angina pectoris]

Area of Science:

• Cardiovascular Medicine
• Minimally Invasive Surgery
• Biomedical Engineering

Context:

• Coronary artery disease (CAD) with intractable angina poses challenges for patients unsuitable for traditional revascularization (coronary artery bypass grafting or percutaneous transluminal coronary angioplasty).
• Transmyocardial laser revascularization (TMR) emerged as a treatment, demonstrating clinical symptom improvement and enhanced exercise capacity in randomized trials.
• TMR necessitates surgical thoracotomy, carrying significant morbidity and mortality risks.

Purpose:

• To evaluate catheter-based systems for percutaneous myocardial revascularization (PMR) as an alternative to TMR.
• To assess the efficacy of PMR in improving clinical symptoms and exercise capacity.
• To investigate the underlying pathophysiologic mechanisms and perfusion changes associated with PMR.

Summary:

• Percutaneous myocardial revascularization (PMR) systems utilize Holmium: YAG lasers transmitted via optical fibers to create myocardial channels from within the left ventricular cavity.
• PMR has shown significant improvements in clinical symptoms (e.g., Canadian Cardiovascular Society [CCS] classification by ~1.5 classes) and exercise capacity, comparable to TMR.
• Despite clinical benefits, robust evidence for improved myocardial perfusion following PMR is currently lacking, and its precise pathophysiologic mechanisms, including neoangiogenesis and denervation, require further elucidation.

Impact:

• PMR presents a less invasive therapeutic option for refractory angina patients, potentially reducing the morbidity associated with TMR.
• The findings highlight the need for further research into the mechanisms of PMR and objective measures of myocardial perfusion to validate its long-term efficacy.
• This technology could expand treatment options for patients with severe coronary artery disease who have exhausted conventional therapies.